gemcitabine
Showing 1 - 25 of 1,156
Pancreatic Cancer Trial in Hangzhou (Canagliflozin and Gemcitabine, Gemcitabine)
Not yet recruiting
- Pancreatic Cancer
- Canagliflozin and Gemcitabine
- Gemcitabine
-
Hangzhou, Zhejiang, ChinaHangzhou first people's Hospital
Jun 11, 2023
Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)
Not yet recruiting
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Baltimore, MarylandSKCCC Johns Hopkins
Aug 16, 2023
Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Minsk (Gemcitabine, ELENAGEN)
Active, not recruiting
- Ovarian Cancer
- Platinum-resistant Ovarian Cancer
- Gemcitabine
- ELENAGEN
-
Minsk, BelarusMinsk City Clinical Oncology Center
Jul 27, 2023
Cholangiocarcinoma Trial in Houston (Pembrolizumab, Gemcitabine, Cisplatin)
Not yet recruiting
- Cholangiocarcinoma
- Pembrolizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 21, 2023
Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreas Cancer
- Non-Resectable Pancreas Carcinoma
- Gemcitabine
- Nab paclitaxel
-
Aalborg, DenmarkDepartment of Oncology, Aalborg University Hospital
May 1, 2023
Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)
Not yet recruiting
- Biliary Tract Carcinoma
- Gemcitabine
- +2 more
-
Beijing, ChinaChinese Academy of Medical Sciences & Peking Union Medical Colle
Apr 10, 2023
Urinary Bladder Cancer Trial in Tucson (Gemcitabine)
Not yet recruiting
- Urinary Bladder Cancer
- Gemcitabine
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Dec 21, 2022
Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- Penpulimab
- +3 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023
Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Gemcitabine
- supportive care
-
Cairo, EgyptAin Shams University Hospital
Dec 20, 2022
Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)
Active, not recruiting
- Pancreatic Cancer
- Gemcitabine
- +3 more
-
Boston, Massachusetts
- +1 more
Jan 9, 2023
Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Gemcitabine
- +3 more
-
Washington, District of ColumbiaLombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023
Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Gemcitabine, Cisplatin)
Recruiting
- Nasopharyngeal Carcinoma
- Camrelizumab
- +3 more
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 3, 2023
Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Gemcitabine
- +3 more
-
Washington, District of ColumbiaLombardi Comprehensive Cancer Center, Georgetown University
Apr 11, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Shanghai (Ascorbate, Nab paclitaxel, Gemcitabine)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Ascorbate
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Cancer Center
Aug 29, 2023
Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)
Active, not recruiting
- Malignant Pleural Mesothelioma
- Mesothelioma
- Cisplatin
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023
Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)
Not yet recruiting
- Biliary Tract Carcinoma
- +2 more
- Gemcitabine
- +3 more
-
Madison, WisconsinUniversity of Wisconsin
Sep 15, 2023
Breast Cancer, Breast Tumors Trial in Charlottesville (drug, device, other)
Recruiting
- Breast Cancer
- Breast Neoplasms
- Gemcitabine
- +2 more
-
Charlottesville, VirginiaUniversity of Virginia
May 17, 2022
Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Resectable Pancreatic Cancer
- Nab paclitaxel
- +2 more
- (no location specified)
Dec 5, 2022
Soft Tissue Sarcoma Trial in Winston-Salem (drug, radiation, procedure, other)
Recruiting
- Soft Tissue Sarcoma
- Gemcitabine
- +4 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Jan 26, 2023
Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)
Not yet recruiting
- Metastatic Triple-Negative Breast Cancer
- Trilaciclib
- +3 more
-
Charlotte, North CarolinaLevine Cancer Institute
Aug 31, 2023
Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,
Not yet recruiting
- Pancreatic Cancer, Stage IB
- +3 more
- sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jan 4, 2023
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Indianapolis (Lonsurf, Gemcitabine, Nab-Paclitaxel)
Active, not recruiting
- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
- Lonsurf
- +2 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Nov 29, 2022
Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)
Active, not recruiting
- Solid Tumor
- Urethral Cancer
- Bortezomib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Cholangiocarcinoma Non-resectable Trial in Chengdu (Candonilimab, Cisplatin, Gemcitabine)
Recruiting
- Cholangiocarcinoma Non-resectable
- Candonilimab
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Aug 4, 2023